The global lateral flow assay market size was USD 16.18 billion in 2023, calculated at USD 16.8 billion in 2024 and is expected to reach around USD 24.39 billion by 2034, expanding at a CAGR of 3.8% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Lateral Flow Assay Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Lateral Flow Assay Market, by Product, 2024-2034
8.1.1. Kits & Reagents
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Lateral Flow Readers
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Lateral Flow Assay Market, by Application, 2024-2034
9.1.1. Clinical Testing
9.1.1.1. Market Revenue and Forecast (2021-2034)
10.1. Lateral Flow Assay Market, by Technique, 2024-2034
10.1.1. Sandwich Assays
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Competitive Assays
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Multiplex Detection Assays
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Lateral Flow Assay Market, by Test Type, 2024-2034
11.1.1. Lateral Flow Immunoassay
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Nucleic Acid Lateral Flow Assay
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. Lateral Flow Assay Market, by End-User, 2024-2034
12.1.1. Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Diagnostic Laboratories
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Home Care
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Pharmaceutical & Biotechnology Companies
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.3. Market Revenue and Forecast, by Technique (2021-2034)
13.1.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.1.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Technique (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.1.6.5. Market Revenue and Forecast, by End-User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Technique (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.1.7.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.3. Market Revenue and Forecast, by Technique (2021-2034)
13.2.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.2.5. Market Revenue and Forecast, by End-User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Technique (2021-2034)
13.2.7. Market Revenue and Forecast, by Test Type (2021-2034)
13.2.8. Market Revenue and Forecast, by End-User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Technique (2021-2034)
13.2.10. Market Revenue and Forecast, by Test Type (2021-2034)
13.2.11. Market Revenue and Forecast, by End-User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Technique (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.2.13. Market Revenue and Forecast, by End-User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Application (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Technique (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.2.15. Market Revenue and Forecast, by End-User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.3. Market Revenue and Forecast, by Technique (2021-2034)
13.3.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.3.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Technique (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.3.7. Market Revenue and Forecast, by End-User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Technique (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.3.9. Market Revenue and Forecast, by End-User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Technique (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Technique (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.3. Market Revenue and Forecast, by Technique (2021-2034)
13.4.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.4.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Technique (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.4.7. Market Revenue and Forecast, by End-User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Technique (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.4.9. Market Revenue and Forecast, by End-User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Technique (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End-User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Technique (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.3. Market Revenue and Forecast, by Technique (2021-2034)
13.5.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.5.5. Market Revenue and Forecast, by End-User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Technique (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.5.7. Market Revenue and Forecast, by End-User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Technique (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Test Type (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End-User (2021-2034)
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. F. Hoffmann-La Roche AG
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. F. Hoffmann-La Roche AG
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bio-Rad Laboratories, Inc
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. bioMérieux SA
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Quidel Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Hologic, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PerkinElmer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Merck KGaA
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client